News

OptimizeRx Announces Pricing of Public Offering of Common Stock

09 February 2021

ROCHESTER, Mich., Feb. 09, 2021 -- OptimizeRx Corporation (Nasdaq: OPRX) (“OptimizeRx”), a leading provider of digital health solutions for life science companies, physicians and patients, today announced the pricing of the previously announced underwritten public offering of 1,325,000 shares of its common stock at a price to the public of $49.50 per share.

Read press release here.

FIND US AT THE POINT OF CARE

WE INTEGRATE DIRECTLY INTO THE EHR

SCHEDULE A DEMO